| Literature DB >> 31242822 |
Wentao Wang1,2, Yang Sheng2, Sua Yoo2, Rachel C Blitzblau2, Fang-Fang Yin1,2, Q Jackie Wu1,2.
Abstract
PURPOSE: To develop an automated optimization program to generate optimal beam settings for whole-breast radiation therapy driven by clinically oriented goals.Entities:
Keywords: automation; beam geometry; breast cancer; optimization; treatment planning; whole breast radiation therapy
Mesh:
Year: 2019 PMID: 31242822 PMCID: PMC6598321 DOI: 10.1177/1533033819858661
Source DB: PubMed Journal: Technol Cancer Res Treat ISSN: 1533-0338
Figure 1.Study workflow. The proposed automated treatment planning workflow consists of 3 steps: initial beam calculation, beam optimization, and fluence optimization. The first 2 steps and the evaluation of automatic plans are described in this work.
Figure 2.Beam geometry settings user interface. The default settings for the tangent only geometry (left) and the tangent plus SCV geometry (right) are shown. SCV indicates supraclavicular.
Dose Metrics Comparison Between Automatic and Clinical Plans. The Numbers in Each Cell are Reported as the Mean Value (Standard Deviation).
| PTV_Eval V95%, % | Lung V20Gy, % | Heart | Maximum Dose, % Rx | CI | ||
|---|---|---|---|---|---|---|
| Tangent test set | Clinical | 94.4 (3.5) | 12.9 (5.4) | 2.2 (1.4) | 108.7 (1.4) | 1.40 (0.16) |
| Auto | 94.5 (2.7) | 9.8 (5.1) | 2.0 (1.0) | 109.1 (0.6) | 1.32 (0.10) | |
|
| 0.846 | 0.049a | 0.416 | 0.516 | 0.062 | |
| SCV test set | Clinical | 82.6 (7.8) | 23.0 (8.6) | 2.4 (1.5) | 109.2 (2.9) | 1.43 (0.52) |
| Auto | 87.5 (6.2) | 20.7 (8.0) | 2.7 (1.6) | 108.5 (1.4) | 1.45 (0.54) | |
|
| 0.037a | 0.232 | 0.049a | 0.316 | 0.977 | |
| All test sets | Clinical | 88.5 (8.4) | 17.9 (8.7) | 2.3 (1.4) | 108.9 (2.2) | 1.41 (0.38) |
| Auto | 91.0 (5.9) | 15.2 (8.6) | 2.4 (1.4) | 108.8 (1.1) | 1.38 (0.38) | |
|
| 0.079 | 0.025a | 0.466 | 0.727 | 0.239 | |
Abbreviations: CI, conformity index; PTV, planning target volume; Rx, prescription dose; SCV, supraclavicular.
aIndicates statistical significance.
Figure 3.Planning target volume (PTV) coverage (PTV_Eval V95%) and lung sparing (ipsilateral lung V20Gy) comparison between automatic plans and clinical plans. The horizontal axis is the difference (automatic-clinical) of PTV_Eval V95%, and positive direction on the axis means better PTV coverage; the vertical axis is the difference (clinical-automatic) of ipsilateral lung V20Gy, and positive direction on the axis means better lung sparing. Different patient groups are separated and denoted with different markers as shown in the legend.
Figure 4.Dose distribution comparison in the same axial slice of one example case between (A) the automatic plan and (B) the clinical plan. The thick green line is the 95% isodose line, and the thin purple line is the PTV_Eval contour on this slice. The white arrows point to the same position at the edge of the lung (note the distance to the 95% isodose line). This case shows how the automatic plan improves the sparing of the lung without sacrificing the PTV coverage. PTV indicates planning target volume.
Figure 5.Dose distribution in the same axial slice of one example case in the automatic plan with default lung weighting factor of 0.05 (A), the clinical plan (B), and the automatic plan with increased lung weighting factor of 0.2 (C). The thick green line is the 95% isodose line, and the thin orange line is the PTV_Eval contour on this slice. The arrows point to the same position at the edge of the PTV_Eval contour. This case shows how the automatic plan improves the PTV coverage at the expense of increasing the lung dose and how the lung weighting factor affects the dose coverage. PTV indicates planning target volume.